Literature DB >> 22114202

Endogenous adenosine contributes to renal sympathetic neurotransmission via postjunctional A1 receptor-mediated coincident signaling.

Edwin K Jackson1, Dongmei Cheng, Stevan P Tofovic, Zaichuan Mi.   

Abstract

Adenosine A(1) receptor antagonists have diuretic/natriuretic activity and may be useful for treating sodium-retaining diseases, many of which are associated with increased renal sympathetic tone. Therefore, it is important to determine whether A(1) receptor antagonists alter renal sympathetic neurotransmission. In isolated, perfused rat kidneys, renal vasoconstriction induced by renal sympathetic nerve simulation was attenuated by 1) 1,3-dipropyl-8-p-sulfophenylxanthine (xanthine analog that is a nonselective adenosine receptor antagonist, but is cell membrane impermeable and thus does not block intracellular phosphodiesterases), 2) xanthine amine congener (xanthine analog that is a selective A(1) receptor antagonist), 3) 1,3-dipropyl-8-cyclopentylxanthine (xanthine analog that is a highly selective A(1) receptor antagonist), and 4) FK453 (nonxanthine analog that is a highly selective A(1) receptor antagonist). In contrast, FR113452 (enantiomer of FK453 that does not block A(1) receptors), MRS-1754 (selective A(2B) receptor antagonist), and VUF-5574 (selective A(3) receptor antagonist) did not alter responses to renal sympathetic nerve stimulation, and ZM-241385 (selective A(2A) receptor antagonist) enhanced responses. Antagonism of A(1) receptors did not alter renal spillover of norepinephrine. 2-Chloro-N(6)-cyclopentyladenosine (highly selective A(1) receptor agonist) increased renal vasoconstriction induced by exogenous norepinephrine, an effect that was blocked by 1,3-dipropyl-8-cyclopentylxanthine, U73122 (phospholipase C inhibitor), GF109203X (protein kinase C inhibitor), PP1 (c-src inhibitor), wortmannin (phosphatidylinositol 3-kinase inhibitor), and OSU-03012 (3-phosphoinositide-dependent protein kinase-1 inhibitor). These results indicate that adenosine formed during renal sympathetic nerve stimulation enhances the postjunctional effects of released norepinephrine via coincident signaling and contributes to renal sympathetic neurotransmission. Likely, the coincident signaling pathway is: phospholipase C → protein kinase C → c-src → phosphatidylinositol 3-kinase → 3-phosphoinositide-dependent protein kinase-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22114202      PMCID: PMC3289416          DOI: 10.1152/ajprenal.00495.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  63 in total

Review 1.  Purinoceptors in the kidney.

Authors:  Zhengrong Guan; David A Osmond; Edward W Inscho
Journal:  Exp Biol Med (Maywood)       Date:  2007-06

2.  Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats.

Authors:  John H Dubinion; Zaichuan Mi; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2006-03-14       Impact factor: 4.030

3.  Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney.

Authors:  Oliver Vonend; Johannes Stegbauer; Johann Sojka; Sina Habbel; Ivo Quack; Bernard Robaye; Jean-Marie Boeynaems; Lars Christian Rump
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 4.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

Authors:  Puja K Mehta; Kathy K Griendling
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-26       Impact factor: 4.249

5.  Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction.

Authors:  E Y Lai; A Patzak; A Steege; R Mrowka; R Brown; N Spielmann; P B Persson; B B Fredholm; A E G Persson
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

6.  Mechanism of the vascular angiotensin II/alpha2-adrenoceptor interaction.

Authors:  Edwin K Jackson; Liping Gao; Chongxue Zhu
Journal:  J Pharmacol Exp Ther       Date:  2005-05-18       Impact factor: 4.030

7.  The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.

Authors:  Howard C Dittrich; Dinesh K Gupta; Terrence C Hack; Thomas Dowling; Janice Callahan; Scott Thomson
Journal:  J Card Fail       Date:  2007-10       Impact factor: 5.712

8.  Lack of contribution of P2X receptors to neurally mediated vasoconstriction in the rabbit kidney in vivo.

Authors:  G A Eppel; S Ventura; K M Denton; R G Evans
Journal:  Acta Physiol (Oxf)       Date:  2006-03       Impact factor: 6.311

9.  Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway.

Authors:  Mairéad A Carroll; Anabel B Doumad; Jing Li; Monica K Cheng; J R Falck; John C McGiff
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14

10.  The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.

Authors:  Michael M Givertz; Barry M Massie; Tara K Fields; Leeanne L Pearson; Howard C Dittrich
Journal:  J Am Coll Cardiol       Date:  2007-10-01       Impact factor: 24.094

View more
  10 in total

Review 1.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

2.  Role of A1 receptors in renal sympathetic neurotransmission in the mouse kidney.

Authors:  Edwin K Jackson; Dongmei Cheng; Zaichuan Mi; Jonathan D Verrier; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

3.  Alkaline Phosphatase Activity Is a Key Determinant of Vascular Responsiveness to Norepinephrine.

Authors:  Edwin K Jackson; Dongmei Cheng; Vladimir B Ritov; Zaichuan Mi
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

4.  Adenosine Receptors Influence Hypertension in Dahl Salt-Sensitive Rats: Dependence on Receptor Subtype, Salt Diet, and Sex.

Authors:  Edwin K Jackson; Delbert G Gillespie; Zaichuan Mi; Dongmei Cheng
Journal:  Hypertension       Date:  2018-06-25       Impact factor: 10.190

5.  Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine.

Authors:  Edwin K Jackson; Yumeng Zhang; Dongmei Cheng
Journal:  Hypertension       Date:  2017-01-30       Impact factor: 10.190

6.  Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.

Authors:  Weiru Zhang; Yujin Zhang; Wei Wang; Yingbo Dai; Chen Ning; Renna Luo; Kaiqi Sun; Louise Glover; Almut Grenz; Hong Sun; Lijian Tao; Wenzheng Zhang; Sean P Colgan; Michael R Blackburn; Holger K Eltzschig; Rodney E Kellems; Yang Xia
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

7.  Characterization of the N6-etheno-bridge method to assess extracellular metabolism of adenine nucleotides: detection of a possible role for purine nucleoside phosphorylase in adenosine metabolism.

Authors:  Edwin K Jackson; Delbert G Gillespie; Dongmei Cheng; Zaichuan Mi; Elizabeth V Menshikova
Journal:  Purinergic Signal       Date:  2020-05-04       Impact factor: 3.765

Review 8.  The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges.

Authors:  Joana Beatriz Sousa; Carmen Diniz
Journal:  Molecules       Date:  2017-05-06       Impact factor: 4.411

9.  Interactive roles of CD73 and tissue nonspecific alkaline phosphatase in the renal vascular metabolism of 5'-AMP.

Authors:  Edwin K Jackson; Dongmei Cheng; Jonathan D Verrier; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-02

10.  Role of CD73 in Renal Sympathetic Neurotransmission in the Mouse Kidney.

Authors:  Edwin K Jackson; Dongmei Cheng; Zaichuan Mi; Jonathan D Verrier; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Physiol Rep       Date:  2013-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.